On Thursday, there are stocks with unusual volume. Let's take a look.
By Mill Chart
Last update: Apr 18, 2024
Which stocks have an unusual volume on Thursday?
Top unusual volume stocks
| Ticker | Change | Comment |
|---|---|---|
| SNGX | -11.78% | 4.32M shares of SOLIGENIX INC (NASDAQ:SNGX) have been traded so far today. NASDAQ:SNGX is experiencing a downward trend, with a decline of 11.78%. The average daily volume over the past 50 days is 3.12M. Hence, the current volume is 38.34% above the average volume, indicating a deviation from the usual trading pattern. |
| INDO | 11.35% | With 3.61M shares traded so far, INDONESIA ENERGY CORP LTD (NYSEARCA:INDO) is experiencing an unusual level of activity today. Leading to a price increase of 11.35%. This is 76.92% above the average daily volume of the last 50 days. |
| SPEC | -20.1% | SPECTAIRE HOLDINGS INC (NASDAQ:SPEC) has an unusual volume of 1.6M shares today. This decline in share price leads to a decrease of 20.1%. The average volume over the last 50 days is 1.21M, making today's volume 31.85% above the average. This signifies a notable change in market participation. Yesterday the company had a press release: Spectaire Announces Strategic Distribution Partnership with a Fortune 1000 Energy Company. |
| VIAO | 1.92% | VIA OPTRONICS AG's (NYSE:VIAO) traded a high volume of 1.3M shares. The share price increased by 1.92%. Compared to the average daily volume of the past 50 days, the current volume is 256.0% above, suggesting an unusual level of trading activity. |
| TIRX | 65.43% | The stock of TIAN RUIXIANG HOLDINGS LTD-A (NASDAQ:TIRX) has caught attention with a significant volume of 53.69M shares today. Leading to a price increase of 65.43%. In comparison to the average daily volume of the last 50 days, the current volume is 10.0K% above. This suggests a notable change in trading activity. |
| MRNS | 2.43% | MARINUS PHARMACEUTICALS INC (NASDAQ:MRNS) has an unusual volume of 2.92M shares. The market is favoring NASDAQ:MRNS today, as its share price records a notable increase of 2.43%. The average volume over the last 50 days is 1.82M, making today's volume 60.82% above the average. This signifies a notable change in market participation. |
| DFLI | 14.65% | 3.87M shares of DRAGONFLY ENERGY HOLDINGS CO (NASDAQ:DFLI) exchanged hands today. Leading to a price increase of 14.65%. The average volume over the last 50 days is 709.15K, making today's volume 446.0% above the average. This signifies a notable change in market participation. |
| MOB | -0.98% | MOBILICOM LTD/AUSTRALIA's (NASDAQ:MOB) traded a high volume of 840.13K shares. The share price experienced a decrease of 0.98%. This volume is 210.0% above the average 50 day volume. Earlier today the company had a press release: Mobilicom and Airbus complete successful integration and flight proof-of-concept on Airbus Mid-Sized Jet-UAV for long-range operations. |
| HUSA | 2.75% | The trading volume of HOUSTON AMERICAN ENERGY CORP (NYSEARCA:HUSA) today is 830.97K shares, which is considered unusual. NYSEARCA:HUSA is experiencing an advancement of 2.75% in its share price today. The average volume measured over 50 days is 634.18K, so this is 31.03% above the average volume. |
| GL | 1.79% | Today's trading session witnessed an unusual volume of 3.28M shares for GLOBE LIFE INC (NYSE:GL). The market is favoring NYSE:GL today, as its share price records a notable increase of 1.79%. The average daily volume over 50 days is 2.44M, so this is 34.6% above the average volume. |
To see the full list of unusual volume stocks you can use our unusual volume stocks screener.
SOLIGENIX INC
NASDAQ:SNGX (5/17/2024, 8:28:34 PM)
After market: 0.385 -0.01 (-1.94%)0.3926
+0 (+0.67%)
SNGX News
3 days ago - Soligenix, Inc.Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
6 days ago - BusinessInsiderSNGX Stock Earnings: Soligenix Beats EPS, Misses Revenue for Q1 2024InvestorPlace - Stock Market News, Stock Advice & Trading Tips Soligenix (NASDAQ:SNGX) just reported results for the first quarter of 2024.Sol...
6 days ago - InvestorPlaceSNGX Stock Earnings: Soligenix Beats EPS, Misses Revenue for Q1 2024SNGX stock results show that Soligenix beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
9 days ago - ChartmillWhich stocks are moving after the closing bell on Friday?What's going on in today's after hours session
9 days ago - Soligenix, Inc.Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
13 days ago - Soligenix, Inc.Soligenix to Present at Upcoming Conferences/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
24 days ago - Soligenix, Inc.Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
a month ago - Soligenix, Inc.Soligenix Announces Pricing of $4.75 Million Public Offering/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing...
a month ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayPre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Thursday morning!
On Monday, Soligenix Inc (NASDAQ:SNGX) received an FDA orphan drug designation for the active ingredient in MarVax, the subunit protein vaccine of recombinantly expressed Marburg marburgvirus (MARV) glycoprotein, for the prevention and post-exposure prophylaxis against MARV infection. In addition to providing a seven-year term of market exclusivity upon final FDA approval, orphan drug designation also positions Soligenix to be able to leverage a wide range of financial and regulatory benefits, i
a month ago - InvestorPlaceWhy Are Stocks Up Today?Stocks are up today and investors wondering what's behind that rally have come to the right place as we have the latest news for Monday!
